Altered kynurenine and indole tryptophan pathways in calcific aortic stenosis: cross-sectional evidence for a gut-host metabolic imbalance (GUT-CAS)
Chong-Nguyen, C., Atighetchi, S., Ferro, C., Yilmaz, B., Macpherson, A., Sokol, H., Siepe, M., Reineke, D., et al.
cardiovascular medicine
Quick verdict
GUT-CAS ties aortic stenosis to a kynurenine-over-indole tryptophan shift; candid, exploratory, and FDR-fragile, with confounder-sensitive severity link.
Summary
This single-center prospective cohort study (Bern; NCT06021535) enrolled 54 calcific aortic stenosis (CAS) patients and 41 BMI-matched controls, integrating full-length 16S rRNA sequencing (PacBio HiFi), targeted serum/fecal metabolomics (LC-MS/MS of bile acids, SCFAs, choline/TMAO and tryptophan pathways), and two-sample Mendelian randomization (MR) against a large CAS GWAS. The principal result is an elevated kynurenine-to-indole-3-sulfate ratio in CAS (p=0.0031, q=0.013), the only FDR-significant finding among four prespecified tryptophan ratios; individual kynurenine-pathway metabolites and indole-3-sulfate reached only nominal or suggestive significance. The ratio correlated inversely with indexed aortic valve area (rho=-0.310, n=46), but not after age/BMI adjustment (p=0.111). Microbiome alpha/beta diversity and community structure were unchanged, with only nominally depleted Lachnospiraceae taxa. MR identified lipoprotein(a) as causal (Wald OR 1.116), while tryptophan metabolites behaved as downstream markers in reverse MR. Strengths include isotope-dilution absolute quantification, unusually candid FDR reporting (the pooled 19-test q=0.059 is disclosed), and systematic confounder sensitivity analyses. Key limitations: no replication cohort, single-center exploratory design, fragile FDR significance contingent on the ratio-family choice, a severity association that does not survive confounder adjustment, small female subgroup (n=13), and unavailable data.
Review complete
Assessment at a glance
6
risk flags identified
● high 0
● medium 3
● low 3
5 strengths · 5 weaknesses · 5 author questions
Levels reflect verification complexity — not a quality score. Evolve never rates your paper.
Key claims under review
- Calcific aortic stenosis is associated with a selective shift of tryptophan metabolism toward the kynurenine pathway, captured by an elevated kynurenine-to-indole-3-sulfate ratio (the only FDR-significant finding, q=0.013).
- This metabolic shift occurs in the absence of global gut microbiome differences in alpha/beta diversity or community structure.
- The KI ratio inversely correlates with indexed aortic valve area unadjusted (rho=-0.310, n=46), but this association is attenuated and non-significant after adjustment for age and BMI.
- Mendelian randomization supports lipoprotein(a) as a genetically causal CAS risk factor (Wald OR 1.116), while tryptophan metabolites act as downstream markers of CAS-related inflammation rather than causal drivers.
- Male CAS patients show a stronger kynurenine-pathway signal than female patients, an exploratory finding requiring replication (no significant CAS-by-sex interaction).
Strengths
Integrated multi-modal design in one registered cohort
Combines full-length 16S rRNA sequencing (PacBio HiFi, V1-V9, DADA2/QIIME2), targeted LC-MS/MS of four metabolite classes, and bi-directional MR against the Kany et al. 2025 GWAS (45,352 cases) — a rare gut-host-causality triangulation for valvular disease, with ethics approval and NCT06021535 registration.
Metabolite ratios are analytically interpretable
Absolute quantification via stable isotope-labeled internal standards (MRM transitions listed in Supplementary Table 1) makes the kynurenine/indole-3-sulfate ratio a genuine concentration ratio rather than an artifact of relative-abundance pipelines.
Unusually transparent negative and sensitivity reporting
Renal confounding pre-empted for the key metabolite
High-resolution microbiome profiling with covariate control
Weaknesses
FDR significance hinges on the family definition
Severity claim does not survive adjustment
Integrated claim spans partially different populations
Reverse MR contradicts the observational direction
Small, confounded, non-replicated cohort
Full Review Report
$1.99 · one-timeUnlock the complete preliminary analysis Evolve produced for this paper.
- All 5 strengths & 5 weaknesses, analyzed in detail
- 6 risk flags with severity, section & reviewer questions
- Methods & statistical evidence assessment
- 5 questions a peer reviewer would ask
- Full six-dimension evaluation report & recommendations
One-time purchase · this paper only
One-time purchase, this paper only. AI-generated preliminary analysis — not peer review.
Frequently asked questions
What did the GUT-CAS study find in calcific aortic stenosis patients?
Comparing 54 patients with calcific aortic stenosis (CAS) to 41 BMI-matched controls, the study found a shift of tryptophan metabolism toward the kynurenine pathway: the ratio of kynurenine to indole-3-sulfate was significantly higher in CAS after FDR correction (p=0.0031, q=0.013), while overall gut microbiome diversity was unchanged. The finding is exploratory and has not been validated in an independent cohort.
Is the kynurenine-to-indole ratio a biomarker of aortic stenosis severity?
Not yet. In the study, the ratio correlated with smaller indexed aortic valve area without adjustment (Spearman rho about -0.31, n=46), but the association was no longer significant after adjusting for age and BMI (p=0.111). It is a hypothesis-generating cross-sectional signal, not a validated severity marker.
Did the study show that gut bacteria cause aortic stenosis?
No. Mendelian randomization found no forward causal effect of tryptophan metabolites on aortic stenosis; it supported lipoprotein(a) as a causal risk factor, with kynurenine and indole metabolites behaving as downstream markers of inflammation. The observed metabolite differences are cross-sectional associations only.
What are the main limitations of this medRxiv preprint (GUT-CAS)?
It is a single-center exploratory study without an independent replication cohort; the primary FDR-significant result depends on testing only four prespecified ratios (pooled testing gives q=0.059); the severity correlation fails confounder adjustment; the female subgroup had only 13 patients; data and code are not publicly available; and the preprint has not been peer reviewed.
About this review
This is an AI-generated preliminary review by Evolve.Pub, produced from the openly available text of the paper. It is not peer review and does not represent the authors' views. The canonical record of the paper is at the publisher link above.
- Supplementary tables (22) and figures (7) — where most FDR-adjusted subgroup, sensitivity and MR detail resides — are not included in the extracted text; reported q-values cannot be independently verified.
- Table 1 baseline characteristics values are absent from the extraction, so the claimed balance on sex, BMI, CAD and risk factors could not be checked numerically.
- Figures are available only as captions; visual inspection of distributions (e.g., the Figure 6 scatter, Figure 3 violins) was not possible.
- This is a non-peer-reviewed medRxiv preprint (posted 2026-09-16); the review reflects the extracted preprint text only.
Go deeper on this paper
Wrote a paper? Stress-test it before reviewers do.
Upload your manuscript for the same structured scrutiny — reasoning, statistics, evidence, figures, and reproducibility.